(Photo Courtesy: www.fslawfirm.com)
California-based TriLink BioTechnologies announced that it has entered into a distribution agreement with India-based inVentis Technologies (Inventis)
inVentis is a distribution and manufacturing company specializing in the life science and applied science, research, diagnostics and QC market.
The agreement allows inVentis to market TriLink's complete line of nucleic acid-based products.
This includes TriLink's stocked and custom nucleotides, oligonucleotides, and mRNA, as well as CleanAmp Hot Start PCR Products.
"With the biotech industry growing rapidly in India, TriLink has been looking for the right opportunity to enter the market. InVentis provides an extensive line of life science products to the biotech and pharmaceutical market and we feel that our high quality nucleic acid-based products will complement their offering and help advance research in the area," commented TriLink's president and CEO, Dr Richard Hogrefe.
